ICON to Webcast Analyst Day Meeting
09 Mai 2014 - 12:00PM
Business Wire
ICON plc, (NASDAQ:ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and
medical device industries, today announced that it will provide a
live webcast of its Analyst Day meeting which will take place on
Wednesday, 14th May, 2014 in North Wales, Philadelphia, starting at
9:30 a.m. EST. The event will include presentations from members of
ICON’s executive team. It is expected that the presentations,
followed by a question and answer session, will conclude by
approximately 12:15 p.m. EST.
This webcast and accompanying slide presentation will be
accessible live from our website at http://investor.iconplc.com. A
recording will also be available on the website for 90 days
following the webcast. In addition, a calendar of company events,
including upcoming conference presentations, is available on our
website, under “Investors”. This calendar will be updated
regularly.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. With
headquarters in Dublin, Ireland, ICON currently, operates from 76
locations in 37 countries and has approximately 10,300 employees.
Further information is available at www.iconplc.com.
All at ICON.
ICON/ICLR-F
ICON plcInvestor Relations1-888-381-7923orBrendan Brennan, + 353
–1-291-2000Chief Financial OfficerorSimon Holmes, + 353
–1-291-2000EVP Investor Relations and Corporate Development
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024